TotalMarketCap

COMPASS Pathways

CMPSNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.106 B

$7.81 -9.24%

Close of 6 Nov 2026

As of 6 Nov 2026, COMPASS Pathways (CMPS) has a market capitalization of $1.11B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$269.8M

Loss-making

Shares outstanding

141,710,353

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #140Amphastar PharmaceuticalsAMPH$1.18B
  2. #141VerastemVSTM$1.15B
  3. #142COMPASS PathwaysCMPS$1.11B
  4. #143Seaport TherapeuticsSPTX$1.09B
  5. #144Janux TherapeuticsJANX$985.5M

What if COMPASS Pathways were worth as much as…

Open the what-if tool →

Gold $28.2T

$199,257.66

Per share 25,529× higher

Bitcoin $1.53T

$10,781.49

Per share 1,381× higher

Apple $5.02T

$35,394.61

Per share 4,535× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for COMPASS Pathways are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.